Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
eBay
EBAY
$46.3B
| $75M | 0.14% |
2,956,827
+375,255
| +15% | +$9.36M |
|
152
Ally Financial
ALLY
$13.1B
| $74.7M | 0.14% |
3,331,331
+748,158
| +29% | +$16.5M |
|
153
Cognizant
CTSH
$27.9B
| $74.6M | 0.14% |
1,220,870
+28,571
| +2% | +$1.79M |
|
154
Aramark
ARMK
$15.8B
| $74.4M | 0.14% |
3,326,345
-974,414
| -23% | -$22M |
|
155
Abbott
ABT
$202B
| $73.9M | 0.14% |
1,504,880
+1,434,730
| +2,045% | +$68.9M |
|
|
PE
156
DELISTED
PARSLEY ENERGY INC
PE
| $73.6M | 0.14% |
4,224,972
-630,262
| -13% | -$10.9M |
|
157
Ameriprise Financial
AMP
$49.1B
| $73.4M | 0.14% |
587,681
+207,379
| +55% | +$26.4M |
|
158
Sally Beauty Holdings
SBH
$1.55B
| $73.1M | 0.14% |
2,315,053
+1,203,796
| +108% | +$38.2M |
|
|
QLIK
159
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $73M | 0.14% |
2,087,551
+283,571
| +16% | +$10M |
|
|
CAM
160
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $72.9M | 0.14% |
1,392,463
-1,480,636
| -52% | -$76.8M |
|
161
Eastman Chemical
EMN
$8.47B
| $72.8M | 0.14% |
889,268
+665,214
| +297% | +$51.3M |
|
|
QEP
162
DELISTED
QEP RESOURCES, INC.
QEP
| $72.3M | 0.14% |
3,903,770
-783,094
| -17% | -$16.1M |
|
|
FNFG
163
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $72.2M | 0.14% |
7,648,386
+2,661,644
| +53% | +$24.3M |
|
164
JD.com
JD
$39.7B
| $72M | 0.14% |
2,110,173
+1,440,685
| +215% | +$49M |
|
|
PF
165
DELISTED
Pinnacle Foods, Inc.
PF
| $71.7M | 0.14% |
1,575,292
+454,183
| +41% | +$19.2M |
|
166
Coca-Cola
KO
$392B
| $71.3M | 0.13% |
1,818,186
-1,982,820
| -52% | -$80.6M |
|
167
JB Hunt Transport Services
JBHT
$25.9B
| $71.3M | 0.13% |
868,306
+638,847
| +278% | +$55.5M |
|
|
THOR
168
DELISTED
THORATEC CORPORATION
THOR
| $71.1M | 0.13% |
1,596,252
+46,163
| +3% | +$2.02M |
|
|
FOLD
169
DELISTED
Amicus Therapeutics
FOLD
| $71M | 0.13% |
5,019,702
+702,767
| +16% | +$8.45M |
|
|
ESV
170
DELISTED
Ensco Rowan plc
ESV
| $70.7M | 0.13% |
794,166
-367,278
| -32% | -$35.7M |
|
|
CONE
171
DELISTED
CyrusOne Inc Common Stock
CONE
| $70.5M | 0.13% |
2,394,205
+1,266,506
| +112% | +$39.6M |
|
172
Visteon
VC
$2.83B
| $70.3M | 0.13% |
669,841
+268,878
| +67% | +$28.3M |
|
|
PCP
173
DELISTED
PRECISION CASTPARTS CORP
PCP
| $69.9M | 0.13% |
+349,695
| New | +$73.4M |
|
174
Walt Disney
DIS
$186B
| $69.9M | 0.13% |
612,176
-1,283
| -0.2% | -$141K |
|
175
Cencora
COR
$60.7B
| $69.3M | 0.13% |
+651,799
| New | +$73.4M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.